Viral expression vectors
US7132588B2 · kind B2 · utility
1Cited by
10References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 21, 2003 |
| Grant date | Nov 7, 2006 |
| Priority date | — |
| Expiry date | Nov 28, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2770/00043
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention provides nucleic acid sequences having an altered viral movement protein and 126/183 kDa replicase proteins further characterized in its ability tostabilize a transgene contained in a virus that expresses the altered movement protein. The present invention also provides viral vectors expressing the altered movement protein, cells transformed with the vectors, and host plants infected by the viral vectors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.